Sara Zaghlul

Whitehead Institute for Biomedical Research — United States

Medicine · Health Sciences

11h-index2.2kcitations48works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytokine Signaling Pathways and Interactions(20), Heat shock proteins research(19), PARP inhibition in cancer therapy(18), Synthesis and biological activity(12), Lung Cancer Treatments and Mutations(9)

Publications48 total

The SHR/Akr Y chromosome reveals repeated turnover of the rat pseudoautosomal region
2025· 1 citedOpen Access
Supplementary Figure 4 from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Supplementary Figure 2 from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Supplementary Figure 4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
2023Open Access
Supplementary Materials and Figure Legends 1-4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
2023Open Access
Supplementary Figure 5 from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Supplementary Figure 2 from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Data from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
2023Open Access
Supplementary Figure 7 from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Data from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
2023Open Access
Supplementary Figure 3 from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Data from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Supplementary Figure 8 from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Supplementary Figure 1 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
2023Open Access
Supplementary Figure 6 from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Supplementary Figure 5 from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Data from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Supplementary Methods, Legends for Figures 1-8 and Tables 1-3 from Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
2023Open Access
Supplementary Materials and Figure Legends 1-4 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
2023Open Access
Supplementary Figure 3 from Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Kwok‐Kin Wong(41), Robert F. Padera(40), Samanthi A. Perera(39), Kate McNamara(37), Danan Li(37), Hongbin Ji(37), Lucian R. Chirieac(37), Roman K. Thomas(37), Matthew Meyerson(25), Takeshi Shimamura(24), Shigeto Kubo(24), Masaya Takahashi(24), Heidi Greulich(24), Christa L. Borgman(23), Geoffrey I. Shapiro(23), Henry J. Haringsma(22), Elizabeth Liniker(21), April M. Lowell(21), Yuko Minami(21), Susumu Kobayashi(21)